RE: Full of confidence and unconcerned.12 Feb 2023 11:07
@ Waynesmith 1/5/2020....to 12/2/2023 = 2 years + 10 months
MATERIAL TRANSFER AGREEMENT WITH JAPANESE PHARMACEUTICAL COMPANY
London, UK ., 1 May 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, announces that it has signed an agreement with a global Japanese pharmaceutical company to evaluate Valirx's therapeutic, VAL301, for the purpose to contemplate a potential future license, for its use in the treatment of endometriosis.
The Material Transfer Agreement ("MTA") covers the evaluation of VAL 301 in a series of preclinical proof of concept and efficacy studies relating to endometriosis. Studies are also scheduled to consider proprietary delivery methods for the compound.
The Japanese Company has already conducted a thorough review of Valirx's prior data under terms of a confidentiality agreement, and now wishes to use material provided by Valirx to conduct their own experiments.
By way of context, ValiRx has developed its VAL301 decapeptide for use in the treatment of endometriosis, while the Japanese Company has a range of pre-clinical assays for testing drug candidates for use in the treatment of endometriosis, as well as several commercial and developmental products in women's health, and other healthcare areas.
To both parties' mutual potential benefit therefore and under the terms of the MTA, ValiRx will supply the required quantities of compound, while the Japanese sponsor will be responsible for undertaking an agreed programme of work at its own expense.
-ENDS-
REPLY FROM SUZY:- AUG/2022
I know a lot of shareholders think that I clearly don’t work hard enough, if the results aren’t immediately there, but the nature of scientific research is that sometimes time taken can be unpredictable. I can’t recall if you have ever done so, but certainly a lot of shareholders email me (and complain if they don’t get immediate responses) 24/7, so working 5 days a week sounds like a holiday to me! We deal with people in time zones ranging from Japan to California, so it’s never been a 9-5 Monday-Friday job. Just as when doing lab work, weekend working is standard practise, because growing cell lines for example, they don’t just pause for weekends.
So where are the results? Suzy said "it’s never been a 9-5 Monday-Friday job" Seriously!!!.......3 years and we are still waiting and NO UPDATE ON VAL 301!
SUZY, MAKE US BELIEVE IN YOU AGAIN LIKE WE DID WHEN YOU TOOK THE ROLE OF CEO!
Sign In
Follow the stocks
